Apellis Pharmaceuticals, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Apellis Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $444K, a 5.46% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.78M, a 14.9% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2022 was $1.55M, a 12.5% increase from 2021.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.38M, a 116% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.78M +$232K +14.9% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-02-29
2022 $1.55M +$173K +12.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-02-29
2021 $1.38M +$742K +116% Jan 1, 2021 Dec 31, 2021 10-K/A 2024-02-29
2020 $637K +$397K +165% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $240K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.